Epinephrine nasal spray for the treatment of anaphylaxis: perspectives in pediatrics
Based on the current evidence, intranasal epinephrine appears to be a promising, well tolerated option that could significantly improve the accessibility and effectiveness of anaphylaxis management in the pediatric setting.
Authors
- Mattia Giovannini (ORCID: https://orcid.org/0000-0001-9568-6882)
- Francesca Mori (ORCID: https://orcid.org/0000-0001-7483-0128)
- Simona Barni (ORCID: https://orcid.org/0000-0001-5598-2740)
- Benedetta Pessina (ORCID: https://orcid.org/0000-0002-1387-3463)
- Giada Crescioli (ORCID: https://orcid.org/0000-0002-1071-6120)
- Antonella Muraro (ORCID: https://orcid.org/0000-0002-5026-5862)
- Alfredo Vannacci (ORCID: https://orcid.org/0000-0001-5259-2026)
Institutions
- University of Padua (IT)
- Laboratoire de Biophotonique et Pharmacologie (FR)
- Meyer Children's Hospital (IL)
- University of Florence (IT)
Publication Details
- Journal
- Current Opinion in Allergy and Clinical Immunology
- Published
- 2025-09-16
- DOI
- https://doi.org/10.1097/aci.0000000000001109
- Citations
- 3
- Primary Topic
- Food Allergy and Anaphylaxis Research
- Type
- article
- Field-Weighted Citation Impact
- 4.87